This video features the July members meeting of the Equine Spine Initiative, highlighted by a comprehensive clinical case review session led by renowned veterinary neurologist Dr. Steve Reed. Focusing on young horses, particularly Warmbloods and Quarter Horses, the presentation walks through multiple diagnostic dilemmas involving neuroaxonal dystrophy (NAD) and equine degenerative myeloencephalopathy (EDM). A multidisciplinary panel of veterinarians, pathologists, and radiologists dissects the complex intersection of advanced CT imaging, histopathology (such as spheroids in the cuneate nuclei), and the unique challenges of distinguishing true degenerative changes from breed-specific developmental immaturity.
Beyond specific case analyses, the session fosters an open dialogue regarding the future of equine neurology. The participants actively debate the standardization of diagnostic terminology for insurance and owner reporting, explore potential environmental and genetic triggers behind disease clusters, and critique various treatment modalities ranging from multi-level surgical foraminotomies to pharmaceutical interventions like gabapentin and phenytoin. The meeting concludes with a forward-looking discussion on the necessity of collecting normal control samples to better define baseline pathology in growing horses.